Cargando…
Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
Background Colorectal carcinoma (CRC) is the second-leading cause of cancer-related death. Despite the combined (surgery, chemotherapy, radiotherapy, and immunotherapy) modalities of treatment, the prognosis remains poor, mostly because of recurrence and distant metastasis. Cancer stem cells (CSC) a...
Autores principales: | Suman, Sweta, Hota, Subhransu Kumar, Misra, Pranati, Sahu, Nageswar, Sahu, Subrat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387822/ https://www.ncbi.nlm.nih.gov/pubmed/37529823 http://dx.doi.org/10.7759/cureus.41242 |
Ejemplares similares
-
The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022) -
Estimation of Total Platelet Count From Peripheral Blood Smear Needs a Correction Factor
por: Sahu, Nageswar, et al.
Publicado: (2022) -
Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
por: Hong, Injae, et al.
Publicado: (2015) -
Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients
por: Pitule, Pavel, et al.
Publicado: (2014) -
The Role of Immunohistochemical Markers in the Diagnosis of Early Myocardial Infarction
por: Buğra, Aytül, et al.
Publicado: (2022)